| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3899441 | Urology | 2014 | 6 Pages |
Abstract
Our findings add to the growing body of evidence for the many pleiotropic actions of minocycline. In view of the striking effects of minocycline on cell growth in PCA cell lines in vitro and its relatively safe side effect profile, the use of minocycline for targeting PCA should be timely clinically evaluated.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Francesca Regen, Isabella Heuser, Irmelin Herzog, Julian Hellmann-Regen,